Ramaraju Surgical Unlisted Shares
Company Profile
Ramaraju Surgical Cotton Mills Limited (CIN: L17111TN1939PLC002302) was incorporated on February 28, 1939, and is headquartered in Rajapalayam, Tamil Nadu. As part of the Ramco Group, the company transformed Rajapalayam from an agrarian town to an industrial hub. It stands today as India’s largest producer of absorbent cotton, surgical dressings, gauze, and medical-grade yarn, leveraging over 125 tons/month cotton capacity and 30,000 tons/year yarn capacity. Additionally, a captive renewable energy portfolio—including wind and solar—ensures sustainable operations.
Key Areas of Focus
- Medical & Surgical Products: Manufacturing surgical cotton, bandages, gauze, and wound-care items.
- Textiles & Yarn: Producing superfine count ring-spun and open-end yarn for textiles.
- Industrial Fabrics: Supplying grey fabrics and specialty cotton products to diverse industries.
- Renewable Energy: Operating windmills and solar plants for captive power, reducing carbon footprint.
Business Operations and Market Position
RSCML operates four integrated plants in Rajapalayam, Perumalpati, Subramaniapuram, and Thirumalagiri, maintaining a pan-India distribution network. It commands a leading market share in surgical cotton and medical textiles. The company’s consistent R&D investment and strategic alliances underpin its robust position in both domestic and export markets.
Core Product Portfolio
- Surgical Cotton & Dressings: Sterile absorbent cotton, bandages, gauze.
- Medical-Grade Yarn: Superfine ring-spun and open-end yarn for healthcare textiles.
- Grey Fabrics: Industrial and apparel-grade cotton fabrics.
- Wound-Care Products: Specialized wound dressings and cotton-based medical disposables.
Manufacturing Capabilities and Expansion Plans
RSCML’s state-of-the-art facilities feature automated processing, sterilization, and precision weaving. Recent expansions added 15% capacity to yarn and fabric lines. Future plans include a new surgical cotton unit with 50-tonne/month capacity and scaling renewable energy capacity by 20 MW to achieve carbon-neutral growth by 2028.
Promoters & Management
| Name | Designation |
| P.R. Venketrama Raja | Chairman |
| Nalina Ramalakshmi | Managing Director |
| N.R.K. Ramkumar Raja | Managing Director |
| M. Karunakaran | Director |
| N.K. Shrikantan Raja | Director |
| P.J. Alaga Raja | Director |
| P.P.S. Janarthana | Director |
| V. Santhanaraman | Director |
| P.J. Ramkumar Rajha | Director |
| P.A.B. Raju | Director |
Shareholding Patterns
| Shareholder Category | Shares Held | Holding (%) |
| Promoters | 1,812,580 | 45.34 |
| Public & Others | 2,185,320 | 54.66 |
| Total | 3,997,900 | 100.00 |
Company Fundamentals
| Metric | Details |
| Outstanding Shares | 3,997,900 |
| Face Value | ₹10 per equity share |
| ISIN | INE328E01027 |
| Lot Size | 100 shares |
| Paid-up Share Capital | ₹39.98 lakhs |
| Authorized Share Capital | Data available on request |
| Registered Office | PAC Ramasamy Raja Salai, Rajapalayam – 626117, Tamil Nadu |
| Incorporation Date | February 28, 1939 |
| Category / Sub-Category | Public Company limited by shares |
Financials
Consolidated Income Statement (₹ Lakhs)
| Year | Revenue | EBITDA | OPM | PAT | NPM | EPS |
| 2016 | 24,608 | 4,376 | 18% | 1,789 | 7% | 91 |
| 2017 | 24,431 | 3,896 | 16% | 1,662 | 7% | 84 |
| 2018 | 26,365 | 3,367 | 13% | 886 | 3% | 22 |
| 2019 | 25,500 | 2,983 | 12% | -26 | 0% | -1 |
| 2020 | 31,590 | 5,227 | 17% | 1,918 | 6.1% | 49 |
Balance Sheet (₹ Crores)
| Particulars | Mar 31 2023 | Mar 31 2022 |
| Non-Current Assets | ||
| Property, Plant & Equipment | 297.27 | 241.06 |
| CWIP | 9.17 | 24.98 |
| Goodwill | 19.52 | 19.52 |
| Investments in Associates | 187.56 | 182.46 |
| Other Non-Current Assets | 9.22 | 18.03 |
| Total Non-Current Assets | 522.74 | 486.05 |
| Current Assets | ||
| Inventories | 38.11 | 36.12 |
| Trade Receivables | 3.03 | 8.48 |
| Cash & Cash Equivalents | 0.07 | 0.93 |
| Other Current Assets | 28.57 | 33.27 |
| Total Current Assets | 69.78 | 78.80 |
| Total Assets | 592.52 | 564.85 |
| Equity & Liabilities | ||
| Equity Share Capital | 4.00 | 4.00 |
| Other Equity | 258.55 | 288.66 |
| Total Equity | 262.55 | 292.66 |
| Non-Current Liabilities | ||
| Borrowings | 222.37 | 141.40 |
| Provisions & Deferred Grants | 1.05 | 0.97 |
| Total Non-Current Liabilities | 223.42 | 142.37 |
| Current Liabilities | ||
| Borrowings | 200.37 | 184.32 |
| Trade & Other Payables | 11.38 | 16.67 |
| Other Current Liabilities | 21.23 | 25.45 |
| Provisions | 3.91 | 5.39 |
| Total Current Liabilities | 236.89 | 231.83 |
| Total Equity & Liabilities | 592.52 | 564.86 |
Cash Flow Statement (₹ Crores)
| Particulars | FY 2022-23 | FY 2021-22 |
| Net Cash from Operating Activities | -5.51 | 47.07 |
| Net Cash Used in Investing Activities | -67.37 | -50.83 |
| Net Cash from Financing Activities | 66.56 | 9.24 |
| Net Change in Cash | -6.31 | 5.47 |
| Cash & Cash Equivalents (BOY) | 9.42 | 3.91 |
| Cash & Cash Equivalents (EOY) | 3.11 | 9.42 |
Annual Reports and Regulatory Compliance
RSCML files statutory annual reports and financial statements up to FY 2022-23, audited by leading chartered accountants. Regulatory compliance includes RBI registration as an NBFC for its financing arm and MCA filings, ensuring robust governance and transparency.
IPO Preparations and Market Listing Plans
Ramaraju Surgical Cotton Mills Limited has not announced any IPO plans as of mid-2025. However, its strong market position, diversified product lines, and governance framework create a solid foundation for potential future listing once market conditions are favorable.
FAQs – How to Buy or Sell Ramaraju Surgical Unlisted Shares
How can I buy Ramaraju Surgical Unlisted Shares?
Register on UnlistedShareBrokers, complete KYC with PAN, Aadhaar, and demat details, search “Ramaraju Surgical Cotton Mills Limited,” select your lot of 100 shares, and place a secure buy order.
What is the minimum lot size for Ramaraju Surgical Unlisted Shares?
100 shares per transaction, subject to market availability and broker policies.
What documents are required for Ramaraju Surgical Unlisted Shares transactions?
PAN card, Aadhaar card, Client Master Report (CMR), canceled cheque, and an active NSDL/CDSL demat account.
What is the current lock-in period for Ramaraju Surgical Unlisted Shares?
A six-month lock-in from acquisition, per SEBI’s unlisted shares regulation.
How are Ramaraju Surgical Unlisted Shares transferred between accounts?
Via Delivery Instruction Slip (DIS)—submit offline to your DP or execute online e-DIS through your broker’s portal.
What are the current valuation metrics for Ramaraju Surgical?
For Ramaraju Surgical shares, valuation reflects P/E multiples around 15–18x and book value per share of ₹59.15 as of March 2023.
What makes Ramaraju Surgical shares attractive for investment?
Market leadership in surgical cotton, diversified textile lines, strong promoter backing, and renewable energy integration support resilience and growth.
What are the tax implications of Ramaraju Surgical Unlisted Shares transactions?
Short-term gains (≤24 months) taxed at slab rate; long-term gains (>24 months) taxed at 20% with indexation benefits. Dividends taxed per individual bracket.
Can I pledge Ramaraju Surgical Unlisted Shares for loans?
Yes. Quality unlisted shares are acceptable collateral; lenders typically offer 50–70% loan-to-value based on marketability.
What is the outlook for Ramaraju Surgical’s IPO and exit opportunities?
No immediate IPO; primary exit via secondary market liquidity. Strong financials and strategic roadmap may lead to future listing or strategic sale.
